These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6597735)

  • 1. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of deceleration by methylated cyclodextrins in the dehydration of prostaglandin E2 and the isomerization of prostaglandin A2 in aqueous solution.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5093-101. PubMed ID: 3471361
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
    J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives.
    Yoshida A; Yamamoto M; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4075-80. PubMed ID: 3245985
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclodextrin complexation of barbiturates in aqueous solution.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2825-7. PubMed ID: 6524658
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes.
    Vincieri FF; Mazzi G; Papini P; Gelsomini N
    Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770
    [No Abstract]   [Full Text] [Related]  

  • 10. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
    Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solute-induced circular dichroism: complexation of achiral drugs with cyclodextrin.
    Han SM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2822-5. PubMed ID: 6524657
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 14. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
    Green AR; Guillory JK
    J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of beta-cyclodextrin with bile salts in aqueous solutions.
    Miyajima K; Yokoi M; Komatsu H; Nakagaki M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1395-8. PubMed ID: 3731354
    [No Abstract]   [Full Text] [Related]  

  • 16. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
    Miao ZC; Du ZH; Xu GF; Shi TS
    Yao Xue Xue Bao; 1988; 23(9):682-7. PubMed ID: 3256202
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationships between crystallinity of beta-cyclodextrin and tablet characteristics.
    Nakai Y; Yamamoto K; Terada K; Kajiyama A
    Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5110-2. PubMed ID: 3830437
    [No Abstract]   [Full Text] [Related]  

  • 18. Solute-induced circular dichroism: drug discrimination by cyclodextrin.
    Han SM; Atkinson WM; Purdie N
    Anal Chem; 1984 Dec; 56(14):2827-30. PubMed ID: 6524659
    [No Abstract]   [Full Text] [Related]  

  • 19. Formation of a complex between the analgesic, 6-benzoyl-benzoxazolidinone (CERM 10194), and beta-cyclodextrin.
    Si-Nang L; Simond J; Schiff V; Trottier D; Pourrat A
    Pharm Acta Helv; 1985; 60(4):112-6. PubMed ID: 4011622
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversed-phase high-performance liquid chromatographic separation of substituted phenolic compounds with a beta-cyclodextrin bonded phase column.
    Chang CA; Wu Q; Armstrong DW
    J Chromatogr; 1986 Feb; 354():454-8. PubMed ID: 3700535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.